BeOne Medicines Ltd.
ONCNasdaqCIK 1651308HealthcareFiscal year ends Dec 31
Reports and events: 374 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1616:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-108269 |
| 2026-08-2606:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-26-000025 |
| 2026-08-0506:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-052878 |
| 2026-08-0506:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052877 |
| 2026-06-2606:02 ET | 8-K | 8.01 Other events | 0001651308-26-000020 |
| 2026-06-1516:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-074089 |
| 2026-06-1116:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001651308-26-000017 |
| 2026-05-1516:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-26-000012 |
| 2026-05-0606:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-030867 |
| 2026-05-0606:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030866 |
| 2026-04-2806:01 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-049655 |
| 2026-04-1616:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-044411 |
| 2026-04-1409:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-26-000008 |
| 2026-02-2606:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011946 |
| 2026-02-2606:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011941 |
| 2025-12-1906:01 ET | 8-K | 1.02 Termination of a material agreement | 0001651308-25-000153 |
| 2025-12-1806:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001651308-25-000151 |
| 2025-11-1906:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001651308-25-000148 |
| 2025-11-0606:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049824 |
| 2025-11-0606:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049821 |
| 2025-08-2906:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000136 |
| 2025-08-2506:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-041082 |
| 2025-08-0606:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001651308-25-000133 |
| 2025-08-0606:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000131 |
| 2025-05-2116:45 ET | 8-K | 5.07 Shareholder vote results | 0001651308-25-000084 |
| 2025-05-1316:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-002297 |
| 2025-05-1316:03 ET | 8-K | 3.02 Unregistered sale of equity | 0001651308-25-000078 |
| 2025-05-0706:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001651308-25-000075 |
| 2025-05-0706:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000074 |
| 2025-04-2917:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-25-000066 |
| 2025-04-2816:09 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001651308-25-000063 |
| 2025-04-2808:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000057 |
| 2025-04-0706:03 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001104659-25-032346 |
| 2025-03-0321:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-001327 |
| 2025-02-2816:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001651308-25-000036 |
| 2025-02-2706:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001651308-25-000031 |
| 2025-02-2706:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001651308-25-000029 |
| 2025-01-1317:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001651308-25-000012 |
| 2025-01-0806:02 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001651308-25-000005 |
| 2024-12-2306:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000171 |
| 2024-12-1021:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-127397 |
| 2024-12-1006:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001651308-24-000164 |
| 2024-12-0416:05 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-24-006827 |
| 2024-11-1906:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000157 |
| 2024-11-1406:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000154 |
| 2024-11-1206:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001651308-24-000152 |
| 2024-11-1206:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000150 |
| 2024-10-2806:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000139 |
| 2024-09-3006:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001651308-24-000123 |
| 2024-09-2606:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001651308-24-000118 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:05 ET. Listed shows no prices and gives no investment advice.